Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tanios Bekaii-Saab
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Siouxland Regional Cancer Center
Sioux City, Iowa, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Hematology Oncology Associates of Central New York-East Syracuse
East Syracuse, New York, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- Wellmont Medical Associates Oncology and Hematology-Kingsport
Kingsport, Tennessee, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States
- Marshfield Clinic
Marshfield, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Mar 2015
- Primary completion
- 1 Sept 2017
- Completion
- 2 Mar 2023
- Last update posted
- 18 Jun 2025
- Registered enrollment
- 123
- Registry id
- NCT02368886
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.